Although some live by the phrase, ‘An aspirin a day keeps the doctor away,’ the scale weighing aspirin’s benefits and risks has tipped for certain groups.
A small 2024 study from Harvard University found that low-dose aspirin can reduce inflammation triggered by sleep restriction.
A new study links daily aspirin use to reduced cancer risk, but other research suggests the opposite effect in older people.
Aspirin’s cancer-fighting prowess hinges on rallying the body’s immunity to combat malignant cells.
A comprehensive review found that patients who take aspirin have a relatively lower risk of developing various types of cancer.
The wonder of aspirin continues, as the century-old drug has revitalized pharmaceutical giant Bayer AG’s first quarter sales with an astounding 23 percent growth compared to the same quarter last year.